Breast Cancer Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- People who have been diagnosed with breast cancer (including ductal carcinoma, invasive carcinoma, or triple negative breast cancer) and have had no cancer recurrence, OR people who have not had any cancer diagnosis in at least the last 15 years
- People aged between 35 and 75 years
- People whose breast cancer has led to menopause, or people who have gone through natural menopause (for those without a cancer history)
- People who are not currently following a special nutrition or diet programme
- People who have not taken part in any structured exercise programme in the last 3 months, or whose weekly physical activity level is low (confirm with trial site for exact measurement details)
- People who are willing and able to give informed consent to participate
- People who do not have any condition that the research team determines would interfere with the study or make exercise unsafe
Who may not be able to join:
- People for whom a doctor has advised against exercise for medical reasons
- People who have additional surgery planned during the period of the trial
- People who regularly take beta-blocker medications or any drugs that affect how the nervous system works
- People with a history of a second separate primary invasive cancer (for the cancer group), or people who have a serious ongoing chronic illness (for those without a cancer history)
- People with any of the following heart conditions: a heart attack or heart bypass procedure within the last 3 months; uncontrolled high blood pressure; uncontrolled irregular heartbeat; significant heart valve disease; heart failure that is not well managed; or a known aortic aneurysm
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Cristina Blasco Lafarga, Tenured Professor, University of Valencia
Phone: 64372
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Fat oxidation during incremental test; Detrended Fluctuation Analysis
Can't join this trial?
Data last synced from ClinicalTrials.gov: 22 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.